This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The role of a multidisciplinary pre-assessment clinic was evaluated in reducing mortality and costs after complex orthopaedic surgery. This clinic had a specialised multidisciplinary anaesthetist-lead team (including anaesthetist, orthopaedic senior house officer and nurse practitioner) who assessed all patients preoperatively for the need for a high dependency or intensive care unit bed; the bed was booked as part of the preoperative plan. This intervention was compared with patients managed in a post-anaesthesia care unit on the day of surgery (where there had been no consultant-led preoperative anaesthetic assessment clinic), with patients discharged to a ward, a high dependency unit or an intensive care unit.
Location/setting
UK/in-patient secondary care.
Methods

Analytical approach:
The cost-effectiveness analysis was based on a single clinical study. The time horizon was until discharge from hospital. The perspective adopted was not explicitly reported.
Effectiveness data:
Effectiveness data came from a single before-and-after cohort study. Data were collected prospectively from April 2005 up to March 2006 (298 patients) for the first part of the study with no specialised preoperative anaesthetic assessment clinic phase. Data for the specialised preoperative anaesthetic assessment clinic phase was collected from May 2006 up to April 2009 . The main effectiveness measures were: the number of deaths prior to return to the ward or during the stay in post-anaesthesia care, high dependency or intensive care unit; the number of days in post-anaesthesia care, high dependency or intensive care unit; and the number of planned and unplanned admissions to post-anaesthesia care, high dependency or intensive care unit.
Monetary benefit and utility valuations:
None.
